Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Direxion Daily Semiconductor Bull 3X Shares (SOXL) vs 10X Genomics Inc (TXG) Price & Performance

Direxion Daily Semiconductor Bull 3X SharesTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Direxion Daily Semiconductor Bull 3X Shares vs 10X Genomics Inc — how do they compare? Direxion Daily Semiconductor Bull 3X Shares trades at $139.44 (market cap $24.42B), while 10X Genomics Inc trades at $82.5 (market cap $10.07B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 2.4× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily Semiconductor Bull 3X Shares for 15 Days and 10X Genomics Inc for 91 Days on average.

SOXLTXG
Market Cap
$24.42B$10.07B
Volume
100,232,3805,657,286
Sector
Leveraged / InverseHealth
52-Week High
$300.77$97.74
52-Week Low
$30.81$11.48
Typical Hold Time
15 Days91 Days
Enterprise Value
—$9.59B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Direxion Daily Semiconductor Bull 3X Shares

SOXL, the Direxion Daily Semiconductor Bull 3X ETF, trades at $141.3, down 11.08% with a bearish technical signal despite bullish moving averages. The semiconductor sector shows volatility with mixed news flow, ranging from strong AI demand to regulatory and tariff concerns. Recent price action reflects the leveraged ETF's sensitivity to chip stock movements, with support at $134 and resistance at $145.

Outlook remains cautious due to high leverage amplifying sector swings. Opportunities exist if semiconductor fundamentals strengthen, but risks include overcrowded trades and macroeconomic headwinds. Investors should weigh the ETF's structure against direct semiconductor exposure for risk management.

10X Genomics Inc

10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.

The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SOXL
49% Buy51% Sell
Avg holding period · 15 Days
TXG
97% Buy3% Sell
Avg holding period · 91 Days

Top news

Latest headlines on both assets

About Direxion Daily Semiconductor Bull 3X Shares

SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on SOXL →

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG →